BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20022265)

  • 1. Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients.
    Golocheikine A; Nath DS; Basha HI; Saini D; Phelan D; Aloush A; Trulock EP; Hachem RR; Patterson GA; Ahearn JM; Mohanakumar T
    J Heart Lung Transplant; 2010 Apr; 29(4):410-6. PubMed ID: 20022265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience.
    Rao U; Sharma M; Mohanakumar T; Ahn C; Gao A; Kaza V
    Transpl Immunol; 2019 Jun; 54():65-72. PubMed ID: 30794945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
    OʼLeary JG; Demetris AJ; Philippe A; Freeman R; Cai J; Heidecke H; Smith C; Hart B; Jennings LW; Catar R; Everly M; Klintmalm GB; Dragun D
    Transplantation; 2017 Oct; 101(10):2399-2409. PubMed ID: 28665894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody.
    Ionescu DN; Girnita AL; Zeevi A; Duquesnoy R; Pilewski J; Johnson B; Studer S; McCurry KR; Yousem SA
    Transpl Immunol; 2005 Oct; 15(1):63-8. PubMed ID: 16223674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies.
    Herman J; Lerut E; Van Damme-Lombaerts R; Emonds MP; Van Damme B
    Transplantation; 2005 May; 79(10):1435-40. PubMed ID: 15912116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy.
    Nath DS; Tiriveedhi V; Basha HI; Phelan D; Moazami N; Ewald GA; Mohanakumar T
    Transplantation; 2011 May; 91(9):1036-43. PubMed ID: 21383658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute humoral rejection of human lung allografts and elevation of C4d in bronchoalveolar lavage fluid.
    Miller GG; Destarac L; Zeevi A; Girnita A; McCurry K; Iacono A; Murray JJ; Crowe D; Johnson JE; Ninan M; Milstone AP
    Am J Transplant; 2004 Aug; 4(8):1323-30. PubMed ID: 15268735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
    Perera MT; Silva MA; Murphy N; Briggs D; Mirza DF; Neil DA
    Scand J Gastroenterol; 2013 Dec; 48(12):1444-51. PubMed ID: 24131305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.
    Eskandary F; Bond G; Kozakowski N; Regele H; Marinova L; Wahrmann M; Kikić Ž; Haslacher H; Rasoul-Rockenschaub S; Kaltenecker CC; König F; Hidalgo LG; Oberbauer R; Halloran PF; Böhmig GA
    Transplantation; 2017 Mar; 101(3):631-641. PubMed ID: 27120452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of C3d binding donor-specific anti-human leukocyte antigen antibody detection by single antigen beads after kidney transplantation-a retrospective study.
    Pelletier RP; Balazs I; Adams P; Rajab A; DiPaola NR; Henry ML
    Transpl Int; 2018 Apr; 31(4):424-435. PubMed ID: 29265514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-human leukocyte antigen antibodies, vascular C4d deposition and increased soluble c4d in broncho-alveolar lavage of lung allografts.
    Girnita AL; Lee TM; McCurry KR; Baldwin WM; Yousem SA; Detrick B; Pilewski J; Toyoda Y; Jelinek L; Lomago J; Zaldonis D; Spichty KJ; Zeevi A
    Transplantation; 2008 Jul; 86(2):342-7. PubMed ID: 18645500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies.
    Yousem SA; Zeevi A
    Am J Surg Pathol; 2012 Jul; 36(7):987-92. PubMed ID: 22510758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of anti-HLA donor-specific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens.
    Roberts JA; Barrios R; Cagle PT; Ge Y; Takei H; Haque AK; Burns KM; Land GA; Dilioglou S; Bernard DW
    Arch Pathol Lab Med; 2014 Aug; 138(8):1053-8. PubMed ID: 24164556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.
    Saini D; Weber J; Ramachandran S; Phelan D; Tiriveedhi V; Liu M; Steward N; Aloush A; Hachem R; Trulock E; Meyers B; Patterson GA; Mohanakumar T
    J Heart Lung Transplant; 2011 Jun; 30(6):624-31. PubMed ID: 21414808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3d and C4d deposition early after lung transplantation.
    Westall GP; Snell GI; McLean C; Kotsimbos T; Williams T; Magro C
    J Heart Lung Transplant; 2008 Jul; 27(7):722-8. PubMed ID: 18582800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
    Bartel G; Wahrmann M; Schwaiger E; Kikić Ž; Winzer C; Hörl WH; Mühlbacher F; Hoke M; Zlabinger GJ; Regele H; Böhmig GA
    Transpl Int; 2013 Feb; 26(2):121-30. PubMed ID: 23145861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection.
    Tower CM; Reyes M; Nelson K; Leca N; Kieran N; Muczynski K; Jefferson JA; Blosser C; Kukla A; Maurer D; Chandler W; Najafian B
    Transplantation; 2017 Sep; 101(9):2235-2243. PubMed ID: 27846156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement fragment C4d and C3d deposition in pediatric heart recipients with a positive crossmatch.
    Holt DB; Liapis H; Mohanakumar T; Phelan DR; Gandi SK; Huddleston CB; Canter CE
    J Heart Lung Transplant; 2008 Oct; 27(10):1073-8. PubMed ID: 18926396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.